Skip to content
Ioversol
Optiray (ioversol) is a small molecule pharmaceutical. Ioversol was first approved as Optiray 320 on 1988-12-30.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Optiray
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ioversol
Tradename
Company
Number
Date
Products
OPTIRAY 300Liebel-FlarsheimN-019710 RX1992-01-22
1 products, RLD, RS
OPTIRAY 350Liebel-FlarsheimN-019710 RX1992-01-22
1 products, RLD, RS
OPTIRAY 320Liebel-FlarsheimN-019710 RX1988-12-30
1 products, RLD, RS
OPTIRAY 300Liebel-FlarsheimN-020923 RX1999-05-13
1 products, RLD, RS
OPTIRAY 320Liebel-FlarsheimN-020923 RX1998-05-29
1 products, RLD, RS
OPTIRAY 350Liebel-FlarsheimN-020923 RX1998-05-28
1 products, RLD, RS
Show 3 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
optirayNew Drug Application2023-02-17
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
V: Various drug classes in atc
— V08: Contrast media
— V08A: X-ray contrast media, iodinated
— V08AB: Watersoluble, nephrotropic, low osmolar x-ray contrast media
— V08AB07: Ioversol
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameIOVERSOL
INNioversol
Description
Ioversol is an amidobenzoic acid.
Classification
Small molecule
Drug classiodine-containing contrast media
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
O=C(NCC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(N(CCO)C(=O)CO)c1I
Identifiers
PDB—
CAS-ID87771-40-2
RxCUI27792
ChEMBL IDCHEMBL1200614
ChEBI ID—
PubChem CID3741
DrugBankDB09134
UNII IDN3RIB7X24K (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,106 documents
View more details
Safety
Black-box Warning
Black-box warning for: Optiray
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
9 adverse events reported
View more details